An adequate blood pressure requires for proper organ perfusion in the body. Hypertension is known as a sustained elevation of the systemic arterial pressure beyond the physiological range; requires high pressure for adequate tissue perfusion.[1] Hypertension is a complex medical condition. Hypertension is a significant global health concern due to its widespread prevalence and 10 to 12 % all-cause mortality worldwide. Even modest increases in blood pressure are associated with incremental risk; for instance, each 20 mmHg rise in systolic or 10 mmHg rise in diastolic blood pressure doubles the risk of cardiovascular events across a wide age range.[2]
Hypertension has emerged as a major public health concern in India. Community-based studies indicate a prevalence of 25–30% among urban adults and 10–20% among rural adults, with increasing trends noted even among adolescents and young adults. Hypertension contributes significantly to the burden of cardiovascular (CV) diseases in India. Hypertension affects 32.6% of women and 38.7% of men over the age of 20 years in India.[3]
About 80% to 90% of all people who have hypertension are said to have primary hypertension, also referred to as essential hypertension. Essential hypertension is a multifactorial disorder arising from the sedentary lifestyles, dietary transitions, and psychosocial stress, interplay of genetic and neurohumoral. Studies have reported that irrespective of age, patients with essential hypertension exhibit weak autonomic responses as reduced parasympathetic responses.[4]
ANS (autonomic nervous system) is centre to cardiovascular regulation, and its dysfunction plays a crucial role in the pathogenesis and progression of essential hypertension. Parasympathetic branch of ANS; activity predominantly reduces heart rate (negative chronotropy) and slightly modulates atrioventricular conduction but exerts minimal influence on vascular tone by releasing acetylcholine at cardiac muscarinic receptors. Autonomic imbalance affects vascular compliance and microvascular function. Reduced parasympathetic vasoconstriction reduces arterial distensibility, compounding the hemodynamic burden on the left ventricle.[5]
Subtle impairments in parasympathetic responses often appear before overt cardiovascular complications, so autonomic reactivity testing is especially useful in hypertension. In people with hypertension, reduced parasympathetic reflexes activity indicate autonomic imbalance, which serves both as a diagnostic indicator and a potential therapeutic target. [6] The assessment of cardiac parasympathetic activity can be assessed by cardiac autonomic reactivity tests (CARTs). Evaluation of autonomic reactivity not only deepens pathophysiological understanding but also holds promise for prognostication and personalized therapy.
Cardiac autonomic reactivity tests are simple and non-invasive methods for assessing the balance between sympathetic & parasympathetic divisions of cardiovascular autonomic in clinical setting. In this study, we primary investigated the changes in cardiac parasympathetic reactivity in patients of essential hypertension and secondary difference of parasympathetic reactivity tests parameters in male and female. We hypothesized that parasympathetic activity would vary between patients with essential hypertension and in healthy normotensive subject.
The present study was conducted on newly diagnosed essential hypertensive patients in the Department of Physiology in collaboration with Department of Medicine, S.M.S. Medical College and attached Hospitals, Jaipur. It was a hospital based cross sectional and comparative type of analytical study. Data collection was started after obtaining prior ethical approval from the institutional ethics committee. The sample size was 100 in each group to a total of 200 (100 hypertensive patients and 100 age & sex matched healthy normotensives). Each group had 50 male and 50 female participants. A written informed consent was obtained from all participating subjects after explaining the purpose of the study and outcome prior to the commencement of study procedure. Detailed history and anthropometric parameters, resting heart rate (HR) (beats per minute), resting blood pressure (mmHg) were assessed. Blood sample of the recruited subjects were collected to measure fasting glucose (FG), lipid profile using Randox IMOLA RX or Backman counter AU 680 analyser. Inclusion criteria for patients were newly diagnosed hypertensive patients of both sexes, diagnosis based on JNC-7 guidelines of hypertension, age group from 25 to 45 years. Exclusion criteria for participants were subjects with any acute illness, smokers and alcoholics, neuromuscular diseases, cognitive disturbances, pregnancy, history of limb injuries, subjects who were not cooperative.
Cardiac parasympathetic reactivity tests which included heart rate (beats per minute) response to deep breathing (E/I ratio), heart rate (beats per minute (bpm)) response to standing (30:15 ratio), valsalva ratio were assessed using a window based Cardiac Autonomic Neuropathy Analyzer (CANWin) version 1.0 with interpretation by RMS (recorders & Medicare systems pvt. Ltd.) provided by the Department of Physiology, S.M.S. Medical College, Jaipur. CANWin detects sympathetic nervous system and parasympathetic nervous system impairment and diagnose the imbalance. The system uses electrocardiogram (ECG) and autonomic non-invasive blood pressure (NIBP) measurement to conduct tests. Test procedure was properly explained to the subject so as to get the maximum cooperation. The subject was asked to lie supine comfortably in a fully relaxed state and allowed to acclimatize to environmental conditions for 15 minutes before starting the test as anxiety and stress can affect autonomic functions. Tests for parasympathetic reactivity assessment:
[1] Deep breathing: ECG limb leads and electrodes were applied on the subject. The test subject was instructed to perform controlled deep breathing for 6 cycles (1 cycle = 5 seconds deep slow inspiration followed by 5 second slow expiration) in a minute. The breathing activity was measured by simultaneously with the electrocardiogram (ECG). The difference between maximum heart rate during inspiration and minimum heart rate during expiration or the ratio between the longest R-R interval during expiration to shortest R-R interval during inspiration (E:I ratio) was calculated.
[2] Lying to standing test (LST): In the lying to standing test, the subject was asked to change posture from supine to standing within 3 seconds in the following sequence, supine to sitting up with legs extended, swinging the legs across so that they hang down of the edge of the couch, getting off the couch into a standing posture which is maintained for 5 minutes. The HR was recorded serially over time along with recording of ECG for the calculation of the heart rate response. The supine position was reassumed at the end of the test. 30:15 ratio was measured as the ratio of R–R interval at 30th beat after standing ÷ 15th beat after standing.
[3] Valsalva manoeuvre: The subject was asked to blow into the sphygmomanometer graduated tube, attempting to maintain an expiratory pressure of 40 mmHg for 15 seconds with nostrils closed. Four phases of cardiac activity were observed during the performance of the manoeuvre by recording of ECG. Valsalva ratio: Ratio of longest R-R interval after the release of pressure in manoeuvre to shortest R-R interval during manoeuvre.
Mean ± SD were used to expressed quantitative variables. Analysis was done using PRIMER version 6. Outcome Variables were analysed using parametric and non-parametric tests. Significance of difference in mean in both main groups and both subgroups were inferred by the student’s unpaired t-test. Statistical significance was assigned at p-value<0.05.
The mean age of hypertensive patients’ group was found to be statistically non-significant as compared with normotensive subjects’ group. (Table 1). The mean height of hypertensive patients’ group was found to be statistically non-significant as compared with normotensive subjects’ group. (Table 1). The mean weight of hypertensive patients’ group was found to be statistically highly significant as compared with normotensive subjects’ group. (Table 1). The mean BMI of hypertensive patients’ group was found to be statistically highly significant as compared with normotensive subjects’ group. (Table 1).
Table 1: Comparison of anthropometric parameters between hypertensive patients and normotensive subjects
|
Parameters |
Group (mean ± SD) |
p-Value |
Significance |
|
|
Hypertensive patients (n=100) |
Normotensive subjects (n=100) |
|||
|
Age (year) |
36.78 ± 4.46 |
35.56 ± 4.56 |
0.057 |
NS |
|
Height (cm) |
163.48 ± 9.39 |
164.05 ± 9.05 |
0.663 |
NS |
|
Weight (kg) |
71.19 ± 10.78 |
60.32 ± 8.90 |
<0.001 |
HS** |
|
BMI (kg/m2) |
26.69 ± 4.00 |
22.31 ± 1.90 |
<0.001 |
HS** |
NS = Non-Significant, HS** = Highly Significant
The mean FG in hypertensive patients’ group was found to be statistically non-significant as compared with normotensive subjects’ group. (Table 2). The mean cholesterol in hypertensive patients’ group was found to be statistically non-significant as compared with normotensive subjects’ group. (Table 2). The mean HDL in hypertensive patients’ group was found to be statistically non-significant as compared with normotensive subjects’ group. (Table 2). The mean LDL in hypertensive patients’ group was found to be statistically significant as compared with normotensive subjects’ group. (Table2). The mean TG in hypertensive patients’ group was found to be statistically highly significant as compared with normotensive subjects’ group. (Table 2).
Table 2: Comparison of FG and lipid profile between hypertensive patients and normotensive subjects
|
Parameters |
Group (mean ± SD) |
p-Value |
Significance |
|
|
Hypertensive patients (n=100) |
Normotensive subjects (n=100) |
|||
|
FG (mg/dl) |
93.07 ± 7.38 |
91.66 ± 6.43 |
0.151 |
NS |
|
Cholesterol (mg/dl) |
153.11 ± 12.70 |
150.02 ± 13.76 |
0.100 |
NS |
|
HDL (mg/dl) |
46.40 ± 7.11 |
47.95 ± 6.34 |
0.105 |
NS |
|
LDL (mg/dl) |
108.24 ± 10.66 |
103.70 ± 10.19 |
0.002 |
S* |
|
TG (mg/dl) |
120.26 ± 23.08 |
89.40 ± 13.72 |
<0.001 |
HS** |
NS = Non-Significant, S* = significant, HS** = Highly Significant
The mean resting HR in hypertensive patients’ group was found to be statistically highly significant as compared with normotensive subjects’ group. (Table 3). The mean resting SBP in hypertensive patients’ group was found to be statistically highly significant as compared with normotensive subjects’ group. (Table 3). The mean resting DBP in hypertensive patients’ group was found to be statistically highly significant as compared with normotensive subjects’ group. (Table 3).
Table 3: Comparison of resting heart rate and resting blood pressure between hypertensive patients and normotensive subjects
|
Parameters |
Group (mean ± SD) |
p-Value |
Significance |
|
|
Hypertensive patients (n=100) |
Normotensive subjects (n=100) |
|||
|
HR (bpm) |
80.42 ± 6.31 |
72.32 ± 5.02 |
<0.001 |
HS** |
|
SBP (mmHg) |
149.65 ± 5.30 |
118.77 ± 8.07 |
<0.001 |
HS** |
|
DBP (mmHg) |
95.08 ± 3.79 |
74.42 ± 3.84 |
<0.001 |
HS** |
HS** = Highly Significant
The mean E/I ratio in hypertensive patients’ group was found to be statistically highly significant as compared with normotensive subjects’ group. (Table 4). The mean 30:15 ratio in hypertensive patients’ group was found to be statistically highly significant as compared with normotensive subjects’ group. (Table 4). The mean valsalva ratio in hypertensive patients’ group was found to be statistically highly significant as compared with normotensive subjects’ group. (Table 4).
Table 4: Comparison of parasympathetic test parameters between hypertensive patients and normotensive subjects
|
Parameters |
Group (mean ± SD) |
p-Value |
Significance |
|
|
Hypertensive patients (n=100) |
Normotensive subjects (n=100) |
|||
|
E/I ratio |
1.12 ± 0.05 |
1.29 ± 0.07 |
<0.001 |
HS* |
|
30:15 ratio |
1.09 ± 0.04 |
1.23 ± 0.07 |
<0.001 |
HS** |
|
Valsalva ratio |
1.32 ± 0.05 |
1.37 ± 0.05 |
<0.001 |
HS** |
HS** = Highly Significant
The mean E/I ratio in hypertensive male patients’ group was found to be statistically highly significant as compared with hypertensive female patients’ group. (Table 5). The mean 30:15 ratio in hypertensive male patients’ group was found to be statistically non-significant as compared with hypertensive female patients’ group. (Table 5). The mean valsalva ratio in hypertensive male patients’ group was found to be statistically non-significant as compared with hypertensive female patients’ group. (Table 5).
Table 5: Comparison of parasympathetic test parameters between hypertensive male patients and hypertensive female patients
|
Parameters |
Group (mean ± SD) |
p-Value |
Significance |
|
|
Hypertensive male patients (n=100) |
Hypertensive female patients (n=100) |
|||
|
E/I ratio |
1.10 ± 0.04 |
1.14 ± 0.06 |
<0.001 |
HS** |
|
30:15 ratio |
1.09 ± 0.04 |
1.10 ± 0.05 |
0.272 |
NS |
|
Valsalva ratio |
1.32 ± 0.04 |
1.32 ± 0.06 |
1 |
NS |
HS** = Highly Significant, NS = Non-Significant
The mean E/I ratio in normotensive male subjects’ group was found to be statistically non-significant as compared with normotensive female subjects’ group. (Table 6). The mean 30:15 ratio in normotensive male subjects’ group was found to be statistically non-significant as compared with normotensive female subjects’ group. (Table 6). The mean valsalva ratio in normotensive male subjects’ group was found to be statistically non-significant as compared with normotensive female subjects’ group. (Table 6).
Table 6: Comparison of parasympathetic test parameters between normotensive male subjects and normotensive female subjects
|
Parameters |
Group (mean ± SD) |
p-Value |
Significance |
|
|
Normotensive male subjects (n=100) |
Normotensive female subjects (n=100) |
|||
|
E/I ratio |
1.29 ± 0.06 |
1.29 ± 0.08 |
1 |
NS |
|
30:15 ratio |
1.24 ± 0.08 |
1.22 ± 0.06 |
0.160 |
NS |
|
Valsalva ratio |
1.37 ± 0.05 |
1.37 ± 0.06 |
1 |
NS |
NS = Non-Significant
The mean weight of hypertensive patients’ group was found to be higher (71.19 ± 10.78 Kg) as compared with normotensive subjects’ group (60.32 ± 8.90 Kg). (p-value <0.001, Table 1). The mean BMI of hypertensive patients’ group was found to be higher (26.69 ± 4.00 Kg/m2) as compared with normotensive subjects’ group (22.31 ± 1.90 Kg/m2). (p-value <0.001, Table 1). Kaur A et al [7] suggested that the weight gain and higher BMI are associated with hypertension. This is due to the association between a higher BMI and a higher plasma volume and cardiac output which may be a contributory factor for autonomic dysfunction.
The mean LDL in hypertensive patients’ group was found to be higher (108.24 ± 10.66 mg/dl) as compared with normotensive subjects’ group (103.70 ± 10.19 mg/dl). (p-value 0.002, Table2). The mean TG in hypertensive patients’ group was found to be higher (120.26 ± 23.08 mg/dl) as compared with normotensive subjects’ group (89.40 ± 13.72 mg/dl). (p-value <0.001, Table 2). Kumar R et al 2024 [8], Huang L et al 2025 [9] found higher LDL and TG in hypertensive patients than normotensive subjects. Vascular endothelial function is probably the link between higher levels of lipids and hypertension. Vascular endothelial function plays a central role in regulating arterial contractility. Higher level of LDL and TG can influence blood pressure by affecting cell membrane structure and receptor function.
The mean resting HR in hypertensive patients’ group was found to be higher (80.42 ± 6.31 mg/dl) as compared with normotensive subjects’ group (72.32 ± 5.02 mg/dl). (p-value <0.001, Table 3). Many researchers such as Mishra N 2026 [10], Murugesan et al 2013 [11] observed higher resting HR in hypertensive patients than normotensive subjects. Previous studies have also suggested that this might be due to a parasympathetic inhibition in hypertensive subjects drive to the heart.
The mean resting SBP in hypertensive patients’ group was found to be higher (149.65 ± 5.30 mmHg) as compared with normotensive subjects’ group (118.77 ± 8.07 mmHg). (p-value <0.001, Table 3). The mean resting DBP in hypertensive patients’ group was found to be higher (95.08 ± 3.79 mmHg) as compared with normotensive subjects’ group (74.42 ± 3.84 mmHg). (p-value <0.001, Table 3). Essential hypertensive patients have higher SBP and DBP which is confirmed by many studies and hypertension guidelines such as Yu et al 2018 [12], Ma J and Chen X 2022 [13], JNC-7 guidelines [14].
The mean E/I ratio in hypertensive patients’ group was found to be lower (1.12 ± 0.05) as compared with normotensive subjects’ group (1.29 ± 0.07). (p-value <0.001, Table 4). The variation of heart rate induced by respiration is known as sinus arrhythmia. Normally, heart rate increases during inspiration (vagal withdrawal) and decreases during expiration (vagal activation). E:I ratio was reduced in hypertensive patients compare to normotensive subjects may be due to baroreceptor desensitization observed by other studies by Balakrishnan A 2018 [15], Manisundaram S et al 2017 [16], Endukuru CV 2015 [17], Rajkumari R et al 2012 [18].
The mean 30:15 ratio in hypertensive patients’ group was found to be lower (1.09 ± 0.04) as compared with normotensive subjects’ group (1.23 ± 0.07). (p-value <0.001, Table 4). In the present study hypertensive patients had lower 30:15 ratio supported by Balakrishnan A 2018 [15], Endukuru CV 2015 [17], Rajkumari R et al 2012 [18]. Hypertensive patient showed no significant increase in heart rate immediately after standing may be due to decreased baroreceptor sensitivity. When healthy normotensive subject assumes an upright posture from supine position, gravity causes pooling of blood in the lower limbs. Therefore, venous return, cardiac output and arterial blood pressure decreases. This leads to decreased stretch of baroreceptors causing activation of vasomotor centre (VMC), which leads to increase sympathetic discharge, decrease vagal tone and an immediately increase in HR. On supine to standing the heart rate increases until it reaches a maximum at about the 15th beat, after which it slows down to a stable state at about 30th beat due to unloading of the baroreceptors. This decreased blood pressure decreases the firing of baroreceptor impulses to nucleus tractus solitarius (NTS) unloading it from inhibitory influence of baroreceptors on NTS. [19]
The mean valsalva ratio in hypertensive patients’ group was found to be lower (1.32 ± 0.05) as compared with normotensive subjects’ group (1.37 ± 0.05). (p-value <0.001, Table 4). Balakrishnan A 2018 [15], Manisundaram S et al 2017 [16], Endukuru CV 2015 [17], Narhare P et al 2011 [20] observed lower valsalva ratio in hypertensive patients and supported the present study. The changes of the intrathoracic and intra-abdominal pressure associated with the manoeuvre result in a complex cardiovascular response with a concomitant action of several regulatory mechanisms. The rise in intrathoracic pressure reduces venous return and left ventricular preload, setting into motion baroreceptor- mediated reflexes that alter heart rate, vascular tone, and cardiac output. Since the main aim of the reflex mechanisms is to control the arterial blood pressure, their action is based primarily on signals from baroreceptors, although they also reflect the activity of pulmonary stretch receptors and, to a lower degree, chemoreceptors, with different mechanisms acting either in synergism or in antagonism depending on the phase of the manoeuvre. Decreased baroreceptor- mediated reflexes leads to decrease valsalva ratio in hypertensive patients. [21] [22]
The mean E/I ratio in hypertensive male patients’ group was found to be lower (1.10 ± 0.04) as compared with hypertensive female patients’ group (1.14 ± 0.06). (p-value <0.001, Table 5). Saini R et al 2022 [23] also found higher E/I ratio in females than males in the deep breathing test and the difference were found to be statistically significant (p-value <0.05). A developmental difference or the influence of male and female sex hormone levels might be the reason behind this difference. Estrogen has an asserting impact on the heart and circulatory system. Vagal tone is raised by estrogen while decreasing sympathetic activity via increasing the density and activity of muscarinic receptors.
Autonomic dysfunction plays a key role in the development and progression of essential hypertension. Sustained impairment in autonomic cardiovascular modulation to the heart, the kidneys and the peripheral vessels lead to haemodynamic, cardio reactivity and cardiometabolic alterations, which in turn contribute to elevation of BP levels. If sustained over time, these alterations promote hypertension-mediated organ damage (HMOD), ultimately leading to an increased risk of cardiovascular events and mortality. [24]
This study concluded that decreased parasympathetic reactivity in essential hypertensive patients as compared to normotensive subjects. Therapies to increase parasympathetic activity such as yoga, meditation with proper pharmaceutical management can be introduce to the hypertensive patients and follow up with the patients; decreases the morbidity and mortality ratio of cardiovascular complications due to hypertension.
We would extend our thanks to the Department of Medicine of S.M.S. Medical College and Hospital for the constant support.
Nil
Conflicts of interest: there are no conflicts of interest.
[1] Guyton AC, Hall JE. Guyton and Hall Textbook of Medical Physiology. 14th ed. International ed. Philadelphia: Elsevier; 2021. Chapter 14, Overview of the circulation: Pressure, Flow and Resistance. p.176.
[2] Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005 Jan 15;365(9455):217 23. DOI: 10.1016/S0140-6736(05)17741-1
[3] Gupta R, Maheshwari A, Verma N, Narasingan SN, Tripathi K, Joshi S, Manoria PC. InSH Consensus Guideline for the Management of Hypertension, 2023. Hypertens J. 2023;9(3):57 132. doi:10.61081/htnj/23v9i302.
[4] Kitazumi T, Sadakane N, Shimada K, Ozawa T. Effects of age and hypertension on autonomic nervous regulation of circulatory system. Nihon Ronen Igakkai Zasshi. 1985;22:1 12. doi:10.3143/geriatrics.22.1.
[5] Julius S, Nesbitt S. Sympathetic overactivity in hypertension: a moving target. Am J Hypertens. 1996 Nov;9(S4):113S 120S. doi:10.1016/0895-7061(96)00287-7.
[6] Ziemssen T, Siepmann T. The investigation of the cardiovascular and sudomotor autonomic nervous system: a review. Front Neurol. 2019;10:53. doi:10.3389/fneur.2019.00053.
[7] Kaur A, Madhukar M, Dhoat PS, Kaur N. Anthropometric indices and its association with hypertension in Indian population: a study from tertiary care center of North India. J Pharm Bioallied Sci. 2023 Jul;15(Suppl 1):S312 S314. doi:10.4103/jpbs.jpbs_417_22. PMID: 37654358; PMCID: PMC10466672.
[8] Kumar R, Haque SM, Kumar V, Kumari U. Relationship between lipid profiles in patients with hypertension: a hospital based retrospective descriptive study. J Cardiovasc Dis Res. 2024;15(4):[pages]. doi:10.48047/
[9] Huang L, Liu Z, Zhang H, et al. The association between serum lipid profile levels and hypertension grades: a cross-sectional study at a health examination center. High Blood Press Cardiovasc Prev. 2025;32:87 98. doi:10.1007/s40292-024-00683-9.
[10] Mishra N. Evaluation of autonomic nervous system dysfunction in hypertension: A cross sectional study of cardiovascular responses. Int J Curr Pharm Res. 2026;18(1):1580 86.
[11] Murugesan RK, Muralikrishnan K, Kabali B. The role of autonomic dysregulation in newly diagnosed hypertension. Middle East J Sci Res. 2013;16(1):68 72. doi:10.5829/idosi.mejsr.2013.16.01.11577.
[12] Yu Y, Xu Y, Zhang M, Wang Y, Zou W, Gu Y. Value of assessing autonomic nervous function by heart rate variability and heart rate turbulence in hypertensive patients. Int J Hypertens. 2018;2018:4067601. doi:10.1155/2018/4067601
[13] Ma J, Chen X. Advances in pathogenesis and treatment of essential hypertension. Front Cardiovasc Med. 2022;9:1003852. doi:10.3389/fcvm.2022.1003852.
[14] Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560 72. https://doi.org/10.1161/01.HYP.0000107251.49515.c2
[15] Balakrishnan A, Natarajan N. A comparative study on vagal activity in normotensive, pre hypertensive, and hypertensive individuals. Natl J Physiol Pharm Pharmacol. 2018;8:1422 5. doi: 10.5455/njppp.2018.8.0723011072018
[16] Manisundaram S, Tripathy PC, Rajkumar D. Comparative study parasympathetic nerve function test in normal and moderately hypertensive patients. Scholars J Appl Med Sci. 2017;5(3):699 703. doi:10.36347/sjams.2017.v05i03.003.
[17] Endukuru CK, Singh SB. A comprehensive study of autonomic dysfunction in hypertension by assessing autonomic function tests and HRV. Int J Sci Res. 2015;4(5):2851 2856. doi:10.21275/SUB154936.
[18] Rajkumari R, Thiyam J, Javan N. Impaired parasympathetic control of heart rate in patients with hypertension. Biomedicine (India). 2012;32:232 235.
[19] Talele P, Badhe Y, Deshpande S, Kowale A. A comparative study of cardiovascular autonomic functions in stage 1 hypertensive subjects and normotensive subjects. Int J Res Trends Innov. 2017;2(12):8 13. Available from: https://ijrti.org/papers/IJRTI1712002.pdf. (ijrti.org in Bing)
[20] Narhare PM, Chaitra B, Surender T. A comparative study of cardiovascular autonomic function in hypertensive and normotensive people. Proceedings of [conference name not specified]. 2011. Available from: https://api.semanticscholar.org/CorpusID:74261811. (api.semanticscholar.org in Bing)
[21] Pstras L, Thomaseth K, Waniewski J, Balzani I, Bellavere F. The Valsalva manoeuvre: physiology and clinical examples. Acta Physiol. 2016;217:103 119. doi:10.1111/apha.12639.
[22] Karunarathna I, Ranasinghe S. The Valsalva Maneuver Physiologic Mechanisms Clinical Applications and professional Integration. Uva Clinical Research Lab 2025 © Uva Clinical Anaesthesia and Intensive Care ISSN 2827-7198. 2025;
[23] Saini R, Kacker S, Gupta R. Relationship between autonomic functional status and maximal aerobic capacity. J Clin Diagn Res. 2022;16(8):CC17 CC21. doi:10.7860/JCDR/2022/56005/16753.
[24] Parati G, Ochoa JE. Autonomic dysfunction in hypertension. In: Micieli G, Hilz M, Cortelli P, editors. Autonomic disorders in clinical practice. Cham: Springer; 2023. doi:10.1007/978-3-031-43036-7_3.
IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications